Clinical Trial Update: ROCOCO - Low Grade Glioma - Planning Study

View source ↗

Summary

ROCOCO is a completed planning study for low-grade glioma conducted by Maastricht Radiation Oncology. The trial entry indicates the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Low Grade Glioma | Status: COMPLETED